CAMERON SNELL: Open Payments
NPI 1730513052 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$931 in 33 payments from 15 companies in 2025. Trend: 2023 $1,053 · 2024 $581 · 2025 $931
Food & beverage: $853Education: $78
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 9 | $228 |
| Janssen Biotech, Inc. | 4 | $141 |
| Endo USA, Inc. | 1 | $132 |
| UROGEN PHARMA, INC. | 3 | $80 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $70 |
| Ferring Pharmaceuticals Inc. | 2 | $54 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| CSL Behring | 1 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Calyxo, Inc. | 1 | $26 |
Products named: PROVENGE, ERLEADA, XIAFLEX, ADSTILADRIN, JELMYTO, ORGOVYX, Andembry, Nubeqa.
Industry payments across KS — which companies pay providers there.
